Big Molecule Watch
- Henlius Receives Orphan-Drug Designation for HLX22 (anti-HER2 mAb) for Gastric Cancer March 28, 2025 Lihui Bai
- FDA Approves Fresenius’s Denosumab Biosimilars March 27, 2025 Riley Wyberg
- Celltrion Wins Costco Formulary Listing for its Recently Launched Ustekinumab March 25, 2025 Beth Ashbridge
- FDA Accepts BLA for Alvotech and Dr. Reddy’s Denosumab Biosimilars March 20, 2025 Riley Wyberg
- Celltrion Launches STEQEYMA® (ustekinumab-stba) in the United States March 19, 2025 Riley Wyberg
- FDA Approves Celltrion’s OMLYCLO® (omalizumab-igec) March 19, 2025 Tara Thigpen
- Federal Circuit Affirms Denial of Injunction Against Amgen in Aflibercept BPCIA Litigation March 17, 2025 Allegra Padula
- FDA Accepts BLA for Amneal’s Denosumab Biosimilars March 12, 2025 Jenevieve Nutovits
- Biosimilars Webinar: Prosecution and Litigation Trends and Takeaways from BPCIA Litigation March 12, 2025 Sarah Clarke
- Amgen and Fresenius Settle Denosumab BPCIA Case March 11, 2025 Allegra Padula